Следене
Anand Shah
Anand Shah
Потвърден имейл адрес: imperial.ac.uk
Заглавие
Позовавания
Позовавания
Година
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 397 (10285), 1637-1645, 2021
467*2021
In-vitro cytotoxicity activity of Solanum nigrum extract against Hela cell line and Vero cell line
S Patel, N Gheewala, A Suthar, A Shah
Int J Pharm Pharm Sci 1 (1), 38-46, 2009
3782009
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10274), 605, 2021
3132021
Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians
MG Wilson, JH Hull, J Rogers, N Pollock, M Dodd, J Haines, S Harris, ...
British journal of sports medicine 54 (19), 1157-1161, 2020
2352020
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
M Prendecki, C Clarke, H Edwards, S McIntyre, P Mortimer, S Gleeson, ...
Annals of the rheumatic diseases 80 (10), 1322-1329, 2021
2262021
Phagocytosis‐dependent activation of a TLR9–BTK–calcineurin–NFAT pathway co‐ordinates innate immunity to Aspergillus fumigatus
S Herbst, A Shah, M Mazon Moya, V Marzola, B Jensen, A Reed, ...
EMBO molecular medicine 7 (3), 240-258, 2015
1722015
Phagocytosis‐dependent activation of a TLR9–BTK–calcineurin–NFAT pathway co‐ordinates innate immunity to Aspergillus fumigatus
S Herbst, A Shah, M Mazon Moya, V Marzola, B Jensen, A Reed, ...
EMBO molecular medicine 7 (3), 240-258, 2015
1722015
Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis
D Armstrong-James, J Youngs, T Bicanic, A Abdolrasouli, DW Denning, ...
European Respiratory Journal 56 (4), 2020
1302020
A longitudinal study characterising a large adult primary ciliary dyskinesia population
A Shah, A Shoemark, SJ MacNeill, B Bhaludin, A Rogers, D Bilton, ...
European Respiratory Journal 48 (2), 441-450, 2016
1182016
Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis
A Bercusson, T Colley, A Shah, A Warris, D Armstrong-James
Blood, The Journal of the American Society of Hematology 132 (18), 1985-1988, 2018
1012018
Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: a systematic review
R Somayaji, MD Parkins, A Shah, SL Martiniano, MM Tunney, JS Kahle, ...
Journal of Cystic Fibrosis 18 (2), 236-243, 2019
972019
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 399 (10325), 665-676, 2022
752022
Reconciling antimicrobial susceptibility testing and clinical response in antimicrobial treatment of chronic cystic fibrosis lung infections
VJ Waters, TJ Kidd, R Canton, MB Ekkelenkamp, HK Johansen, ...
Clinical Infectious Diseases 69 (10), 1812-1816, 2019
672019
Calcineurin Orchestrates Lateral Transfer of Aspergillus fumigatus during Macrophage Cell Death
A Shah, S Kannambath, S Herbst, A Rogers, S Soresi, M Carby, A Reed, ...
American journal of respiratory and critical care medicine 194 (9), 1127-1139, 2016
562016
The serum opsonin L-ficolin is detected in lungs of human transplant recipients following fungal infections and modulates inflammation and killing of Aspergillus fumigatus
S Bidula, DW Sexton, A Abdolrasouli, A Shah, A Reed, ...
The Journal of infectious diseases 212 (2), 234-246, 2015
532015
H‐ficolin binds Aspergillus fumigatus leading to activation of the lectin complement pathway and modulation of lung epithelial immune responses
S Bidula, DW Sexton, M Yates, A Abdolrasouli, A Shah, R Wallis, A Reed, ...
Immunology 146 (2), 281-291, 2015
482015
A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae
PM George, A Reed, SR Desai, A Devaraj, TS Faiez, S Laverty, A Kanwal, ...
Science translational medicine 14 (671), eabo5795, 2022
462022
A new and clinically relevant murine model of solid-organ transplant aspergillosis
S Herbst, A Shah, M Carby, G Chusney, N Kikkeri, A Dorling, E Bignell, ...
Disease models & mechanisms 6 (3), 643-651, 2013
422013
High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre
A Abdolrasouli, A Scourfield, J Rhodes, A Shah, JS Elborn, MC Fisher, ...
International journal of antimicrobial agents 52 (5), 637-642, 2018
402018
Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
J Periselneris, L Nwankwo, S Schelenz, A Shah, D Armstrong-James
Journal of Antimicrobial Chemotherapy 74 (6), 1701-1703, 2019
352019
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20